Denis Curtin

We are a physician- and scientist-founded healthcare venture capital group, investing broadly across sectors at the Seed & Series A stages. MEDA Ventures rests on the investment activities of its legacy Fund & broader investment portfolio (22 companies, 2 exits, 0 shutdowns since 2019, as of 6/2024).

We are a physician- and scientist-founded healthcare venture capital group, investing broadly across sectors at the Seed & Series A stages. MEDA Ventures rests on the investment activities of its legacy Fund & broader investment portfolio (22 companies, 2 exits, 0 shutdowns since 2019, as of 6/2024).

Holding company.

mProve Health, a Signant Health Company, is a leading provider of mobile technologies for life science companies, helping them connect better with patients. We offer industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessment (eCOA). mProve’s applications are used by 18 of the top 20 pharmaceutical companies, 15,000 clinical research sites in over 60 countries, and they are translated in over 50 languages to support patients across the globe. Learn more at mprove.com. Following 7 years of profitable growth, mProve was acquired by Bracket Global in 2017.

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines